AI assistant
Emergent BioSolutions Inc. — Director's Dealing 2016
Aug 5, 2016
32870_dirs_2016-08-04_0febe6dd-eab0-4c94-a456-804cbc905466.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: Aptevo Therapeutics Inc. (APVO)
CIK: 0001671584
Period of Report: 2016-07-29
Reporting Person: Emergent BioSolutions Inc. (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-07-29 | Common Stock, par value $0.001 per share | J | 20228849 | $0.00 | Acquired | 20229849 | Direct |
| 2016-08-01 | Common Stock, par value $0.001 per share | J | 20229849 | $0.00 | Disposed | 0 | Direct |
Footnotes
F1: On July 29, 2016, Aptevo Therapeutics Inc. ("Aptevo") issued 20,228,849 shares of its common stock to its parent, Emergent Biosolutions Inc ("Emergent"), as partial consideration for Emergent's transfer of its biosciences business to Aptevo.
F2: On August 1, 2016, Emergent made a pro rata distribution of 100% of the outstanding shares of Aptevo common stock to Emergent stockholders of record as of July 22, 2016, the record date for the distribution.
F3: This Form 4/A is being filed to correct a typographical error on the shares acquired, disposed of, and beneficially owned following the acquisition.